Development
Core Scientific, Inc.
CORZ
$12.19
$0.262.18%
NASDAQ
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Net Income | 88.52% | 70.58% | 28.68% | -297.38% | -4,636.52% |
| Total Depreciation and Amortization | -57.34% | -24.13% | 46.54% | 181.11% | 577.70% |
| Total Amortization of Deferred Charges | -89.46% | -85.23% | -29.37% | 228.74% | 419.29% |
| Total Other Non-Cash Items | -120.53% | -97.76% | -59.67% | 311.75% | 1,936.76% |
| Change in Net Operating Assets | 15.12% | 21.15% | 20.66% | 6,371.96% | 1,066.68% |
| Cash from Operations | -68.27% | -19.88% | -50.51% | 401.92% | 461.66% |
| Capital Expenditure | 97.31% | 58.09% | 64.71% | -29.33% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -107.66% | 99.81% | 99.16% | 117.78% | 118.34% |
| Cash from Investing | 99.49% | 80.93% | 82.22% | 52.57% | -39.39% |
| Total Debt Issued | -- | -89.03% | -92.97% | -75.48% | -61.04% |
| Total Debt Repaid | 68.91% | 69.67% | 12.90% | -46.72% | -151.73% |
| Issuance of Common Stock | -- | 4,782.85% | 4,782.85% | 4,782.85% | 4,782.85% |
| Repurchase of Common Stock | -- | 99.94% | 91.91% | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -107.79% | -102.05% | -100.00% | 1,925.59% |
| Cash from Financing | -114.58% | -97.32% | -102.55% | -93.56% | -49.27% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 121.99% | 121.49% | -177.60% | -154.10% | -164.61% |